Skip to content

A Pilot Study to Evaluate the BodyLogic TM System (Mentor) in Augmentation Mammaplasty

Pilot Study to Investigate The BodyLogic TM System (Mentor) in Breast Augmentation.

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00684749
Enrollment
142
Registered
2008-05-28
Start date
2008-05-31
Completion date
2010-12-31
Last updated
2015-02-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Augmentation, Breast Reconstruction

Keywords

Mentor BodyLogic TM System, Breast augmentation, Breast implant choice, Reoperation rates

Brief summary

At a national level of 15%, the reoperation rate following augmentation mammaplasty is too high. We are conducting a survey to examine the pre-operative methods by which plastic surgeons determine implant volume, size, shape and location; and to determine if the Mentor BodyLogicTM System can successfully improve outcomes. We will evaluate how measurements taken using BodyLogicTM influence choice of implant and whether there are any re-operations, particularly for size change. We hypothesize that using this system will help surgeons choose appropriate implants that will decrease the rate of reoperations, especially for size change.

Detailed description

We are planning to survey 10 high volume plastic surgeons that perform at least 10 breast augmentations a month and to collect data on at least 300 patients. The enrollment period will be 3 months. As part of this study, we are having the following steps performed: 1. Complete a 'general preference questionnaire', designed to document current preoperative planning and assessment methods for breast augmentation. 2. For each study patient, a pre-operative BodyLogicTM worksheet will be completed. Then, using the provided Implant Selection Booklet, the actual implant will be selected. The surgeon will maintain a key of the patients, and will identify them to the investigators only by subject number, and return these forms in provided stamped, self-addressed envelopes. 3. The patient returns at 1-3 months and 8-12 months for completion of the respective Body-Logic post-operative worksheets for each visit and the surgeon will send us the data in the provided envelopes periodically. 4. If during the course of the data collection, the surgeon has to re-operate on any patient, he/she will fill the re-operative form and send it to us. 5. Finally, the surgeon will complete a post-study evaluation questionnaire to help us understand how the BodyLogicTM System worked for him/her and how it could be improved.

Interventions

None listed

Sponsors

Mentor Worldwide, LLC
CollaboratorINDUSTRY
University of Minnesota
Lead SponsorOTHER

Study design

Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
22 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Female (age \> 22 years) * Cosmetic Breast Augmentation only * Primary breast augmentation

Exclusion criteria

* Breast reconstruction * Secondary breast augmentation * \<22 years of age

Design outcomes

Primary

MeasureTime frameDescription
Reoperation Rates2 yearsSurgeon completed survey

Secondary

MeasureTime frameDescription
Patient Satisfaction With Outcome1 YearPatient completed a survey regarding outcome
Surgeon Satisfaction With Outcome1 YearPatient completedsurvey regarding outcome

Countries

United States

Participant flow

Recruitment details

Surgeons recruited their own patients in their own offices

Pre-assignment details

as above.

Participants by arm

ArmCount
Total Population
All surgical patients
142
Total142

Baseline characteristics

CharacteristicTotal Population
Age, Categorical
<=18 years
0 Participants
Age, Categorical
>=65 years
0 Participants
Age, Categorical
Between 18 and 65 years
142 Participants
Sex: Female, Male
Female
142 Participants
Sex: Female, Male
Male
0 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
— / —
other
Total, other adverse events
0 / 142
serious
Total, serious adverse events
0 / 142

Outcome results

Primary

Reoperation Rates

Surgeon completed survey

Time frame: 2 years

Population: All patients who were treated in the time period

ArmMeasureValue (NUMBER)
Total PopulationReoperation Rates6 participants
Secondary

Patient Satisfaction With Outcome

Patient completed a survey regarding outcome

Time frame: 1 Year

Secondary

Surgeon Satisfaction With Outcome

Patient completedsurvey regarding outcome

Time frame: 1 Year

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026